SIGA Technologies announced that Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer, or CMO. He will also continue to serve as a director of the SIGA Board of Directors. As EVP and CMO, Varma will lead medical affairs. He will provide support and planning for SIGA efforts to build broader awareness of the risk and public health impact of smallpox, MPOX and other orthopox virus outbreaks and promote strategies in procurement and treatment that can support the highest levels of public and individual safety. He will represent SIGA in engagement with leaders from patient advocacy, medical organizations, professional societies, global and regional health agencies and other public health and defense organizations around the world. Varma joined the SIGA Board of Directors in November 2022. He was previously a Professor of Population Health Sciences and Director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell Medicine, a new center at the university focused on pandemic prevention, preparedness, and response. From 2001-2021, he worked for the U.S. Centers for Disease Control and Prevention in Atlanta, Thailand, China, Ethiopia, and New York City.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SIGA:
- SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
- Biotech Alert: Searches spiking for these stocks today
- SIGA Tech (NASDAQ:SIGA) Soars on Bagging $138M Government Orders
- Siga Technologies announces procurement orders of $138M for Oral and IV TPOXX
- SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
